Alterola Biotech Inc Revenue Growth Rates (ALTA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Alterola Biotech Inc   (ALTA)
 

ALTA's Revenue Growth by Quarter and Year

Alterola Biotech Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALTA Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter March -
3rd Quarter December -
2nd Quarter September 0.00
1st Quarter June 0.00
FY 0.00

ALTAs Annual Revenue
Alterola Biotech Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Alterola Biotech Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Alterola Biotech Inc 's Revenue in the fiscal year 2022 $ 0.00 millions
Alterola Biotech Inc 's Revenue in the fiscal year 2021 $ 0.00 millions
Alterola Biotech Inc 's Revenue in the fiscal year 2020 $ 123.40 millions




ALTA Revenue second quarter 2025 Y/Y Growth Comment
Alterola Biotech Inc in the second quarter 2025 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2025, Alterola Biotech Inc achieved the best Revenue growth in Legal Cannabis industry. While Alterola Biotech Inc ' s Revenue no change of 0% ranks overall at the positon no. in the second quarter 2025.


ALTA Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter March - - - -
3rd Quarter December - - - -
2nd Quarter September - - - -
1st Quarter June - - - 19.39 %
FY   - - - -

Financial Statements
Alterola Biotech Inc 's second quarter 2025 Revenue $ 0.00 millions ALTA's Income Statement
Alterola Biotech Inc 's second quarter 2024 Revenue $ 0.00 millions Quarterly ALTA's Income Statement


ALTA Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter March - - - -
3rd Quarter December - - - -
2nd Quarter September - - - -
1st Quarter June - - - 22.81 %
FY (Year on Year)   - - - -


Back to ALTA Growth rate Comparisons >> Back to ALTA Growth rate Comparisons >>


Revenue second quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Alterola Biotech Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALTA's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALTA's II. Quarter Q/Q Revenue Comment


Alterola Biotech Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Sep 30 2024 period, Alterola Biotech Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Alterola Biotech Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2024 period, Alterola Biotech Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Alterola Biotech Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ALTA's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Sep 30 2024 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
Wk Kellogg Co-0.43%$ -0.434 millions
Borealis Foods Inc-0.49%$ -0.485 millions
Pepsico Inc -0.57%$ -0.571 millions
Procter and Gamble Co-0.61%$ -0.613 millions
Kellanova-0.68%$ -0.676 millions
Coca Cola Co-0.83%$ -0.828 millions
Mannatech Inc-0.96%$ -0.965 millions
Inspire Veterinary Partners Inc-1.71%$ -1.714 millions
Brightview Holdings Inc -1.85%$ -1.855 millions
Stepan Company-2.59%$ -2.593 millions
Natural Alternatives International Inc-2.65%$ -2.650 millions
Brc Inc -2.71%$ -2.709 millions
Treehouse Foods Inc -2.82%$ -2.817 millions
Kraft Heinz Co-2.85%$ -2.846 millions
Edgewell Personal Care Company-3.09%$ -3.089 millions
The Vita Coco Company Inc -3.36%$ -3.360 millions
J and j Snack Foods Corp -3.66%$ -3.663 millions
Olaplex Holdings Inc -3.90%$ -3.896 millions
Cvr Partners Lp-4.13%$ -4.127 millions
Cosciens Biopharma Inc -4.15%$ -4.150 millions
Est e Lauder Companies Inc-4.46%$ -4.463 millions
Hni Corporation-5.55%$ -5.553 millions
Jushi Holdings Inc.-5.76%$ -5.760 millions
Usana Health Sciences Inc -6.05%$ -6.048 millions
Jones Soda Co -6.36%$ -6.360 millions
Seaboard Corporation-7.12%$ -7.119 millions
The Hain Celestial Group Inc -7.37%$ -7.373 millions
Crimson Wine Group Ltd -7.60%$ -7.598 millions
Legend Spices Inc -7.88%$ -7.882 millions
Ingredion Incorporated-8.02%$ -8.018 millions


About Alterola Biotech Inc Revenue Growth Rates (ALTA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Alterola Biotech Inc (CIK 1442999).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477932-24-007731
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Alterola Biotech Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.